Drug intelligence / Profile preview

GPX4 allosteric activator

Development stage
Preclinical
Modality
Small Molecules
01

Overview

A GPX4 allosteric activator is a class of small molecule compounds designed to bind to an allosteric site on glutathione peroxidase 4 (GPX4), thereby enhancing its enzymatic activity. GPX4 is a selenium-dependent antioxidant enzyme that plays a critical role in protecting cells from lipid peroxidation by reducing phospholipid hydroperoxides to their corresponding alcohols. By activating GPX4, these compounds inhibit ferroptosis—an iron-dependent form of regulated cell death—and suppress associated inflammatory pathways, such as the NF-κB pathway. GPX4 allosteric activators, such as PKUMDL-LC-101-D04 (compound 102) and GPX4 activator 1, are being investigated in preclinical research for their potential therapeutic applications in lipid-peroxidation-mediated and ferroptosis-driven conditions, including heart failure with preserved ejection fraction (HFpEF), spinal cord injury, and neurodegenerative diseases.

Other names
GPX4 activatorGPX-4 activatorGPX 4 activatorglutathione peroxidase 4 activatorglutathione peroxidase 4 allosteric activator
02

Targets

GPX4 (Glutathione peroxidase 4)

Beyond the preview

Go deeper on GPX4 allosteric activator.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GPX4 allosteric activator.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call